TRAW: Traws Pharma, Inc. Stock

by  •  • Comments Off on TRAW: Traws Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 13.59
Enterprise Value ($M) -7.23
Book Value ($M) 10.67
Book Value / Share 0.51
Price / Book 1.27
NCAV ($M) 10.65
NCAV / Share 0.51
Price / NCAV 1.28

Profitability (mra)
Return on Invested Capital (ROIC) -1.78
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.83

Liquidity (mrq)
Quick Ratio 2.44
Current Ratio 2.46

Balance Sheet (mrq) ($M)
Current Assets 22.66
Assets 22.68
Liabilities 12.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.23
Operating Income -20.30
Net Income -18.95
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -17.93
Cash from Investing -0.01
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-08 13D Viriom, Inc. 11.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 18,554 108,955 17.03
2024-05-02 3,922 89,555 4.38
2024-05-01 4,048 3,869 104.63
2024-04-30 1,894 475 398.74
2024-04-29 2,880 3,906 73.73

(click for more detail)

Similar Companies
TLSA – Tiziana Life Sciences Ltd TNXP – Tonix Pharmaceuticals Holding Corp.
TPST – Tempest Therapeutics, Inc. TRVN – Trevena, Inc.
TTNP – Titan Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io